Multiple myeloma highlights from ASH 2019
Multiple myeloma highlights from ASH 2019
Glasdegib in combination with azacitidine in patients with untreated higher-risk myelodysplastic syndromes and AML
Addressing the treatment gap for patients with relapsed/refractory primary systemic AL amyloidosis: TOURMALINE-AL1 trial results
Carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma
Challenges and importance of long-term treatment for newly diagnosed multiple myeloma patients; community-based trial data
Novel multi-antigen targeted CAR-NK cell for the treatment of B cell malignancies
Mosunetuzumab induces complete remissions in poor prognosis non-Hodgkin lymphoma patients
City of Hope and ACCC: Current projects and future directions
Surveying the practicalities of geriatric care in USA
Polypharmacy and medication management in geriatric oncology
A dedicated, multidisciplinary support team for palliative care patients
Providing practical tips for completing geriatric assessments